المؤلفون: Ezzat MAF; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Elmasry GF; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt., El-Mageed MMAA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Fouad MA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Pharmaceutical Chemistry Department, School of Pharmacy, NewGiza University, Cairo, Egypt., Abdel-Aziz HA; Department of Applied Organic Chemistry, National Research Center, Giza, Egypt., Elewa SI; Organic Chemistry Department, Faculty of Women's for Arts, Science and Education, Ain Shams University, Cairo, Egypt.

المصدر: Drug development research [Drug Dev Res] 2023 Sep; Vol. 84 (6), pp. 1183-1203. Date of Electronic Publication: 2023 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53* , Antineoplastic Agents*/chemistry, Humans ; Animals ; Mice ; Cyclin-Dependent Kinase 2/metabolism ; Molecular Docking Simulation ; Proto-Oncogene Proteins c-mdm2/metabolism ; Proto-Oncogene Proteins c-mdm2/pharmacology ; Pyridines/pharmacology ; Furans/pharmacology ; Cell Proliferation ; Cell Line, Tumor ; Molecular Structure ; Drug Screening Assays, Antitumor ; Structure-Activity Relationship